DSS, Inc. (DSS)
NYSEAMERICAN: DSS · Real-Time Price · USD
0.9400
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT - Market closed
DSS, Inc. Revenue
In the year 2024, DSS, Inc. had annual revenue of $19.10M, down -26.36%. DSS, Inc. had revenue of $5.42M in the quarter ending December 31, 2024, a decrease of -22.77%.
Revenue (ttm)
$19.10M
Revenue Growth
-26.36%
P/S Ratio
0.34
Revenue / Employee
$190,970
Employees
100
Market Cap
8.37M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 19.10M | -6.84M | -26.36% |
Dec 31, 2023 | 25.93M | -21.37M | -45.18% |
Dec 31, 2022 | 47.31M | 27.03M | 133.33% |
Dec 31, 2021 | 20.28M | 4.91M | 31.95% |
Dec 31, 2020 | 15.37M | -184.00K | -1.18% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Amazon.com | 637.96B |
Toyota Motor | 297.33B |
The Home Depot | 159.51B |
Alibaba Group Holding | 134.51B |
Tesla | 97.69B |
Lowe's Companies | 83.67B |
The TJX Companies | 56.36B |
PDD Holdings | 53.96B |
DSS News
- 2 months ago - DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth - GlobeNewsWire
- 2 months ago - DSS, Inc. Issues Letter to Shareholders - GlobeNewsWire
- 3 months ago - LiveData PeriOp Manager Launched in 88 Veterans Affairs Hospitals - Business Wire
- 7 months ago - DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value - GlobeNewsWire
- 8 months ago - AmericaFirst Funds Trust Announces Changes to Board of Trustees - GlobeNewsWire
- 8 months ago - DSS, Inc. Names Jason Grady as Interim Chief Executive Officer - GlobeNewsWire
- 1 year ago - Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition." - GlobeNewsWire
- 1 year ago - DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market - GlobeNewsWire